Complete 2012 forensic audit documents - Kansas Bioscience ...
Complete 2012 forensic audit documents - Kansas Bioscience ...
Complete 2012 forensic audit documents - Kansas Bioscience ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
any future milestone applications or grant applications will go through the standard review and<br />
approval processes mitigates any potentially inappropriate influence on Mr. Krol’s part.<br />
Please refer to the Relationship Appendix for a depiction of Mr. Krol’s relationship map.<br />
Tony Simpson<br />
Tony Simpson reported to a current member of ICM’s management team while both were<br />
employed by a previous employer. In addition, Mr. Simpson listed that individual and another<br />
current member of ICM’s management team as references. ICM received grant awards from<br />
KBA on October 28, 2008 and January 27, 2009. Mr. Simpson was not employed by KBA until<br />
October 2009. Therefore, Mr. Simpson was not a KBA employee when the grants to ICM were<br />
awarded. Mr. Simpson is now the HBV counselor for ICM. However, the fact that any future<br />
milestone applications or grant applications will go through the standard review and approval<br />
processes mitigates any potentially inappropriate influence on Mr. Simpson’s part.<br />
Please refer to the Relationship Appendix for a depiction of Mr. Simpson’s relationship map.<br />
Relationship maps for other KBA staff and BOD members are presented in the Relationship<br />
Appendix.<br />
Recommendation:<br />
KBA’s Conflict of Interest and Documentation Policy defines Interested Persons as “all Officials<br />
of the Authority and spouses, any children of any age and any persons residing in the residence<br />
of such Officials.” The term “Officials” is defined as “all directors and officers of the Authority<br />
and any other person to whom power has been delegated by the Board of Directors of the<br />
Authority.” However, in an industry sector as narrow as bioscience companies in the state of<br />
<strong>Kansas</strong>, the BOD should consider the need to manage the perception of conflicts of interest<br />
based on previous associations between KBA and its employees and BOD, and those of the<br />
bioscience companies and vendors.<br />
In doing so, the BOD would need to broaden the Conflict of Interest and Documentation Policy<br />
to address the appropriate disclosure of all existing relationships (prior employment/co-workers,<br />
common board or committee membership, personal/social relationships) between KBA’s<br />
employees and BOD members and the employees, owners, directorate and advisors of any<br />
company seeking to transact business with or seeking assistance from KBA.<br />
Furthermore, it is recommended that any BOD member having any financial interest in a client<br />
company or an employment relationship within their immediate family should recuse themselves<br />
and, in addition, physically remove themselves from any and all discussion and authorization of<br />
that project.<br />
Additionally, it is recommended that all Investment Recommendations sent to the Investment<br />
Committee contain a discussion regarding all known potential relationships between KBA<br />
employees and BOD members and the company requesting funding. This analysis should<br />
include relationships disclosed in the conflict of interest disclosure process. Consideration<br />
should also be given to the disclosure of relationships that do not trigger a formal disclosure<br />
under the Conflict of Interest Policy. If no relationships exist, that should be noted as well.<br />
143